ArticleBMC medical informatics and decision making2026
Development and external validation of an interpretable early prediction model for acute kidney injury using TabPFN and routine admission data: a retrospective cohort study.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning-Based Multidimensional Health Decline Prediction Framework: Data-Driven Modeling for the Middle-Aged and Elderly Population.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAcute kidney injury (AKI) is a common and serious complication among hospitalized patients, and early risk stratification remains challenging due to heterogeneous clinical data and limited interpretability of existing prediction models. Foundation models designed for tabular data may enable accurate prediction while preserving interpretability, but their application in early AKI risk assessment has not been fully explored.
objectiveTo develop and externally validate an interpretable early prediction model for AKI using the Tabular Prior-data Fitted Network (TabPFN) based on routinely available admission data.
methodsIn this retrospective cohort study, predictors were restricted to clinical variables recorded within the 24 h prior to hospital admission, and this temporal definition was applied consistently across both the internal cohort and the external MIMIC-IV validation dataset. Time zero was defined as the admission time. Baseline serum creatinine (SCr) was defined as the first creatinine measurement at admission. The primary outcome was in-hospital AKI, defined according to KDIGO SCr criteria as a subsequent rise in creatinine relative to this admission baseline at any time during the index hospitalization. A total of 44,324 patients were included in the development cohort. TabPFN was trained on a stratified subsample and evaluated on a held-out internal test set, and benchmarked against seven conventional machine-learning models. Missing data were handled using multivariate imputation, and model interpretation was performed using SHAP-based attribution analyses. External validation was conducted in the MIMIC-IV database following predefined inclusion criteria and feature harmonization.
resultsIn the internal test set, TabPFN achieved an AUROC of 0.953, outperforming comparator models. External validation demonstrated robust discrimination with an AUROC of 0.859. Calibration analyses indicated good agreement between predicted and observed risks. Attribution analyses identified baseline renal function and acute illness markers as major contributors to model-attributed AKI risk, with heterogeneous association patterns across patient subgroups.
conclusionsUsing routinely available pre-admission data, TabPFN enabled accurate early prediction of in-hospital AKI and provided interpretable risk attribution patterns. These findings suggest potential utility for early risk stratification; however, results are observational and hypothesis-generating, and prospective validation is required before clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.